Zobrazeno 1 - 10
of 40
pro vyhledávání: '"T. Pietrasiewicz"'
Autor:
S J Czuczwar, Z. Kleinrok, G Ossowska, Rafal M. Kaminski, M Kozicka, M Gasior, T. Pietrasiewicz
Publikováno v:
Molecular and Chemical Neuropathology. 33:149-162
Excitatory amino acids participate in the generation of seizure activity. Consequently, the effects of GYKI 52466 [1-(4-aminophenyl)-4-methoxy-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride], an antagonist of glutamate-mediated events, on the
Autor:
Czuczwar Sj, Zdzisław Kleinrok, M Kozicka, Waldemar A. Turski, T. Pietrasiewicz, Maciej Gasior
Publikováno v:
Scopus-Elsevier
CR 2039 [[4-(1H-tetrazol-5-yl)-N-(4-(1H-tetrazol-5-yl]phenylbenza m ide], in doses of 10, 50, and 100 mg/kg i.p., significantly elevated the threshold for electroconvulsions, increasing the CS50 (current strength 50% in mA) values from 6.3 to 7.2, 7.
Autor:
Grażyna Czechowska, Waldemar A. Turski, Stanisław J. Czuczwar, Marek Dziki, T. Pietrasiewicz, Zdzisław Kleinrok
Publikováno v:
European Journal of Pharmacology. 250:1-7
CGP 37849 (1 mg/kg i.p.) enhanced the protective action of carbamazepine, diphenylhydantoin and phenobarbital against maximal electroshock-induced convulsions in mice. At 0.25 mg/kg CGP 37849 was inactive and at 0.5 mg/kg it potentiated the anticonvu
Autor:
Zdzisław Kleinrok, Waldemar A. Turski, Czuczwar Sj, M Kozicka, Maciej Gasior, T. Pietrasiewicz
Publikováno v:
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 8(3)
CR 2039 (4-(1H-tetrazol-5-yl)-N-[4-(1H-tetrazol-5-yl]phenylbenzamide), in doses of 10, 20, and 100 mg/kg i.p., did not modify the seizure pattern observed after subcutaneous pentetrazol, administered at its CD97 of 90 mg/kg for the clonic phase. Howe
Publikováno v:
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. 48(2)
Evidence exists that the 4-10 or 4-9 fragments of adrenocorticotropic hormone (ACTH) produce some behavioral effects in animals and in humans. The present study was designed to investigate whether ACTH 4-9 interferes with the effects of antidepressan
Autor:
T, Pietrasiewicz, I, Zebrowska-Lupina
Publikováno v:
Polish journal of pharmacology. 48(2)
The influence of adrenocorticotropic hormone (ACTH) and prednisone on the effects of amitriptyline (AMI), imipramine (IMI), mianserin (MIA) or nomifensine (NOM) was investigated in forced swimming and in open field tests. ACTH (50 I.U./kg) or prednis
Autor:
Czuczwar Sj, Zdzisław Kleinrok, T. Pietrasiewicz, M Kozicka, G Czechowska, Waldemar A. Turski, Maciej Gasior
Publikováno v:
European Neuropsychopharmacology. 5:389
Autor:
I, Zebrowska-Lupina, A, Porowska, M, Stelmasiak, G, Osowsska, M, Juszkiewicz, B, Klenk-Majewska, T, Pietrasiewicz, Z, Kleinrok
Publikováno v:
Acta poloniae pharmaceutica. 44(1)
Autor:
A, Zejc, K, Kieć-Kononowicz, G, Chłoń, Z, Kleinrok, K, Kolasa, T, Pietrasiewicz, G, Czechowska
Publikováno v:
Polish journal of pharmacology and pharmacy. 41(5)
Several derivatives of diphenylimidazolidine-2,4-dione and diphenylimidazolidin-4-one acetic and propionic acids have been synthesized. Some of them were screened for their effect on the CNS in mice and rats. All the investigated compounds showed an
Publikováno v:
Polish journal of pharmacology and pharmacy. 37(6)
The influence of antidepressants: nomifensine, imipramine, amitriptyline and trazodone on the effect of antiparkinsonian agents: trihexyphenidil and L-DOPA + carbidopa mixture (sinemet) in the model of haloperidol catalepsy was investigated in rats.